MOBI
Mobia Medical, Inc.
Price Chart
Latest Quote
$13.69
-0.04 (-0.29%)
Current Price
| Previous Close | $13.73 |
| Open | $13.82 |
| Day High | $14.02 |
| Day Low | $13.52 |
| Volume | 24,000 |
Stock Information
| Shares Outstanding | 33.25M |
| Total Debt | $49.21M |
| Cash Equivalents | $55.73M |
| Revenue | $38.45M |
| Net Income | $-53.59M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $455.18M |
| EPS (TTM) | $-1.62 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $629.77M |
| Sales | $38.45M |
| Income | $-53.59M |
| Book/sh | $-48.97 |
| Cash/sh | $1.68 |
| Employees | 167 |
Financial Ratios
| Quick Ratio | 5.12 |
| Current Ratio | 6.06 |
| Debt/Eq | 409.26 |
Returns & Margins
| Gross Margin | 81.32% |
| Operating Margin | -140.28% |
| Profit Margin | -139.35% |
Ownership
| Insider Ownership | 7.11% |
| Institutional Ownership | 26.70% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -6.39 |
| P/S | 11.84 |
| P/B | -0.28 |
Analyst Data
| Recommendation | none |
| Target Price | $20.00 |
Technical Indicators
| SMA20 | $13.18 |
| RSI | 49.73 |
| ATR | 1.1593 |
| Shares Float | 22.21M |
| Short Float | 1.79% |
| Short Ratio | 1.30 |
| Rel Volume | 0.10 |
Performance History
| Week | +3.40% |
| Month | +8.65% |
| YTD | +16.51% |
| 10 Years | +16.51% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $13.69 | 24,000 |
| 2026-06-23 | $13.73 | 114,800 |
| 2026-06-22 | $13.87 | 104,400 |
| 2026-06-18 | $14.25 | 804,400 |
| 2026-06-17 | $14.53 | 263,800 |
| 2026-06-16 | $13.24 | 360,500 |
| 2026-06-15 | $11.01 | 333,800 |
| 2026-06-12 | $12.31 | 166,200 |
| 2026-06-11 | $12.32 | 166,600 |
| 2026-06-10 | $12.72 | 197,300 |
| 2026-06-09 | $12.72 | 114,200 |
| 2026-06-08 | $12.70 | 70,100 |
| 2026-06-05 | $12.62 | 89,900 |
| 2026-06-04 | $13.84 | 240,900 |
| 2026-06-03 | $13.73 | 354,000 |
| 2026-06-02 | $13.78 | 941,000 |
| 2026-06-01 | $13.50 | 108,500 |
| 2026-05-29 | $13.10 | 66,600 |
| 2026-05-28 | $13.00 | 64,400 |
| 2026-05-27 | $12.98 | 64,500 |
| 2026-05-26 | $13.16 | 132,300 |
About Mobia Medical, Inc.
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | ||
| Reconciled Cost Of Revenue | $6,065,955 | $3,193,173 |
| Cost Of Revenue | $6,065,955 | $3,193,173 |
| Total Revenue | $32,040,978 | $15,644,398 |
| Operating Revenue | $32,040,978 | $15,644,398 |
| Expenses | ||
| Interest Expense | $967,368 | $969,920 |
| Total Expenses | $78,408,879 | $39,880,688 |
| Other Income Expense | $842,531 | $617,109 |
| Other Non Operating Income Expenses | $842,531 | $617,109 |
| Net Non Operating Interest Income Expense | $-967,368 | $-969,920 |
| Interest Expense Non Operating | $967,368 | $969,920 |
| Operating Expense | $72,342,924 | $36,687,515 |
| Income & Earnings | ||
| Net Income From Continuing Operation Net Minority Interest | $-46,498,188 | $-24,603,014 |
| Net Interest Income | $-967,368 | $-969,920 |
| Normalized Income | $-46,498,188 | $-24,603,014 |
| Net Income From Continuing And Discontinued Operation | $-46,498,188 | $-24,603,014 |
| Total Operating Income As Reported | $-46,367,901 | $-24,236,290 |
| Net Income Common Stockholders | $-46,498,188 | $-24,603,014 |
| Net Income | $-46,498,188 | $-24,603,014 |
| Net Income Including Noncontrolling Interests | $-46,498,188 | $-24,603,014 |
| Net Income Continuous Operations | $-46,498,188 | $-24,603,014 |
| Pretax Income | $-46,492,738 | $-24,589,101 |
| Operating Income | $-46,367,901 | $-24,236,290 |
| Gross Profit | $25,975,023 | $12,451,225 |
| Per Share | ||
| Diluted EPS | $-0.02 | $-1.08 |
| Basic EPS | $-0.02 | $-1.08 |
| Other | ||
| Tax Effect Of Unusual Items | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-45,373,713 | $-23,503,171 |
| Reconciled Depreciation | $151,657 | $116,010 |
| EBITDA (Bullshit earnings) | $-45,373,713 | $-23,503,171 |
| EBIT | $-45,525,370 | $-23,619,181 |
| Diluted Average Shares | $23,050,173 | $23,050,173 |
| Basic Average Shares | $23,050,173 | $23,050,173 |
| Diluted NI Availto Com Stockholders | $-46,498,188 | $-24,603,014 |
| Tax Provision | $5,450 | $13,913 |
| Research And Development | $6,515,249 | $4,243,399 |
| Selling General And Administration | $65,827,675 | $32,444,116 |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Assets | ||
| Net Tangible Assets | $-150,773,587 | $-106,035,803 |
| Total Assets | $48,148,699 | $22,091,037 |
| Total Non Current Assets | $1,791,457 | $916,296 |
| Other Non Current Assets | $53,875 | $21,332 |
| Current Assets | $46,357,242 | $21,174,741 |
| Other Current Assets | $1,942,958 | $299,023 |
| Current Deferred Assets | $934,996 | $0 |
| Inventory | $5,456,757 | $3,429,162 |
| Receivables | $4,435,223 | $2,826,236 |
| Accounts Receivable | $4,435,223 | $2,826,236 |
| Cash Cash Equivalents And Short Term Investments | $33,587,308 | $14,620,320 |
| Cash And Cash Equivalents | $33,587,308 | $14,620,320 |
| Debt | ||
| Total Debt | $8,435,336 | $7,720,766 |
| Long Term Debt And Capital Lease Obligation | $8,077,814 | $7,697,120 |
| Long Term Debt | $7,129,928 | $7,094,070 |
| Current Debt And Capital Lease Obligation | $357,522 | $23,646 |
| Liabilities | ||
| Total Liabilities Net Minority Interest | $198,922,286 | $128,126,840 |
| Total Non Current Liabilities Net Minority Interest | $188,716,079 | $123,530,034 |
| Derivative Product Liabilities | $865,390 | $1,007,342 |
| Current Liabilities | $10,206,207 | $4,596,806 |
| Other Current Liabilities | $1,323,498 | $499,534 |
| Payables And Accrued Expenses | $8,011,857 | $3,877,703 |
| Payables | $2,222,970 | $1,139,326 |
| Accounts Payable | $2,222,970 | $1,139,326 |
| Equity | ||
| Common Stock Equity | $-150,773,587 | $-106,035,803 |
| Total Equity Gross Minority Interest | $-150,773,587 | $-106,035,803 |
| Stockholders Equity | $-150,773,587 | $-106,035,803 |
| Retained Earnings | $-157,789,133 | $-111,290,945 |
| Preferred Securities Outside Stock Equity | $179,772,875 | $114,825,572 |
| Other | ||
| Ordinary Shares Number | $33,085,391 | $33,085,391 |
| Share Issued | $33,085,391 | $33,085,391 |
| Tangible Book Value | $-150,773,587 | $-106,035,803 |
| Invested Capital | $-143,643,659 | $-98,941,733 |
| Working Capital | $36,151,035 | $16,577,935 |
| Capital Lease Obligations | $1,305,408 | $626,696 |
| Total Capitalization | $-143,643,659 | $-98,941,733 |
| Additional Paid In Capital | $7,006,706 | $5,247,375 |
| Capital Stock | $8,840 | $7,767 |
| Common Stock | $8,840 | $7,767 |
| Long Term Capital Lease Obligation | $947,886 | $603,050 |
| Current Capital Lease Obligation | $357,522 | $23,646 |
| Pensionand Other Post Retirement Benefit Plans Current | $513,330 | $195,923 |
| Current Accrued Expenses | $5,788,887 | $2,738,377 |
| Net PPE | $1,737,582 | $894,964 |
| Accumulated Depreciation | $-304,405 | $-225,969 |
| Gross PPE | $2,041,987 | $1,120,933 |
| Leases | $848,302 | $568,276 |
| Other Properties | $1,068,452 | $438,588 |
| Machinery Furniture Equipment | $125,233 | $114,069 |
| Properties | $0 | $0 |
| Finished Goods | $4,265,207 | $1,911,162 |
| Raw Materials | $1,191,550 | $1,518,000 |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Free Cash Flow | ||
| Free Cash Flow | $-46,059,401 | $-24,356,149 |
| Operating Activities | ||
| Operating Cash Flow | $-45,694,990 | $-24,315,301 |
| Cash Flow From Continuing Operating Activities | $-45,694,990 | $-24,315,301 |
| Operating Gains Losses | $-141,952 | - |
| Investing Activities | ||
| Capital Expenditure | $-364,411 | $-40,848 |
| Investing Cash Flow | $-364,411 | $-40,848 |
| Cash Flow From Continuing Investing Activities | $-364,411 | $-40,848 |
| Financing Activities | ||
| Issuance Of Capital Stock | $64,712,687 | $14,986,642 |
| Financing Cash Flow | $65,026,389 | $15,658,269 |
| Cash Flow From Continuing Financing Activities | $65,026,389 | $15,658,269 |
| Net Preferred Stock Issuance | $64,712,687 | $14,986,642 |
| Preferred Stock Issuance | $64,712,687 | $14,986,642 |
| Other | ||
| Interest Paid Supplemental Data | $931,510 | $969,920 |
| Income Tax Paid Supplemental Data | $2,725 | $13,913 |
| End Cash Position | $33,587,308 | $14,620,320 |
| Beginning Cash Position | $14,620,320 | $23,318,200 |
| Changes In Cash | $18,966,988 | $-8,697,880 |
| Proceeds From Stock Option Exercised | $313,702 | $671,627 |
| Net PPE Purchase And Sale | $-364,411 | $-40,848 |
| Purchase Of PPE | $-364,411 | $-40,848 |
| Change In Working Capital | $-923,683 | $-634,721 |
| Change In Other Current Assets | $-2,611,473 | $-288,570 |
| Change In Payables And Accrued Expense | $5,324,372 | $1,286,208 |
| Change In Accrued Expense | $4,240,728 | $1,394,802 |
| Change In Payable | $1,083,644 | $-108,594 |
| Change In Account Payable | $1,083,644 | $-108,594 |
| Change In Inventory | $-2,027,595 | $-245,409 |
| Change In Receivables | $-1,608,987 | $-1,386,950 |
| Changes In Account Receivables | $-1,608,987 | $-1,386,950 |
| Other Non Cash Items | $35,858 | $35,857 |
| Stock Based Compensation | $1,446,702 | $758,127 |
| Unrealized Gain Loss On Investment Securities | $234,616 | $12,440 |
| Depreciation Amortization Depletion | $151,657 | $116,010 |
| Depreciation And Amortization | $151,657 | $116,010 |
| Depreciation | $151,657 | $116,010 |
| Gain Loss On Investment Securities | $-141,952 | - |
| Net Income From Continuing Operations | $-46,498,188 | $-24,603,014 |
Fetched: 2026-06-20